More hostile takeovers ‘likely’ as UK tax regime attracts businesses

by Calum Fuller

More from this author

12 May 2014

  • Financial Director
  • Comments
pfizer-6790806

FURTHER HOSITLE TAKEOVER ATTEMPTS similar to that of AstraZeneca by US pharmaceutical Pfizer are likely to take place as foreign businesses seek to take advantage of the UK's attractive corporate tax regime.

The UK's headline rate will be 20% from next April, compared with 35% in the US. Meanwhile, the government has sought to increase the country's attractiveness with tax incentives such as the Patent Box - a 10% tax regime for profits from UK and other European patents - and R&D tax credits.

Baker Tilly tax partner George Bull said: "Like it or not, UK governments over the last decade have constructed a tax system which, although it may not cause the acquisition of British crown jewels by overseas investors, certainly encourages it.

"Although the bid is not being driven by tax considerations, these do play an important part in the structure and timing of the deal. At a stroke, Pfizer can use profits accumulated outside the USA - and not yet taxed in the USA - to acquire AstraZeneca and by reorganising under a new UK holding company, can permanently avoid high US taxes on such profits."

Visitor comments

blog comments powered by Disqus
display:none

Add your comment

We won't publish your address


By submitting a comment you agree to abide by our Terms & Conditions

Your comment will be moderated before publication

Submit

Newsletters

Get the latest financial news sent directly to your inbox

  • Best Practice
  • Business
  • Daily Newsletter
  • Essentials

Careers

Search for jobs
Click to search our database of all the latest accountancy roles

Create a profile
Click to set up your profile and let the best recruiters find you

Jobs by email
Sign up to receive regular updates with the latest roles suitable for you

Briefings

budget-management

Why budgeting fails: One management system is not enough

If budgeting is to have any value at all, it needs a radical overhaul. In today's dynamic marketplace, budgeting can no longer serve as a company's only management system; it must integrate with and support dedicated strategy management systems, process improvement systems, and the like. In this paper, Professor Peter Horvath and Dr Ralf Sauter present what's wrong with the current approach to budgeting and how to fix it.

cchcover

iXBRL: Taking stock. Looking forward

In this white paper CCH provide checklists to help accountants and finance professionals both in practice and in business examine these issues and make plans. Also includes a case study of a large commercial organisation working through the first year of mandatory iXBRL filing.